Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B

Published:2020-06-11 Issue:6 Volume:33 Page:885-893
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Chon Hye Yeon,Seo Yeon Seok,Lee Jung il,Kim Byung Seok,Jang Byoung Kuk,Kim Sang Gyune,Suk Ki Tae,Kim In Hee,Lee Jin-Woo,Chon Young Eun,Kim Moon Young,Jeong Soung Won,Lee Han Ah,Yim Sun Young,Um Soon Ho,Lee Hyun Woong,Lee Kwan Sik,Song Jeong Eun,Lee Chang Hyeong,Chung Woo Jin,Hwang Jae Seok,Yoo Jeong-Ju,Kim Young Seok,Kim Dong Joon,Lee Chang Hun,Yu Jung Hwan,Ha Yeon Jung,Kim Mi Na,Lee Joo Ho,Hwang Seong Gyu,Kang Seong Hee,Baik Soon Koo,Jang Jae Young,Suh Sang Jun,Jung Young Kul,Kim Beom Kyung,Park Jun Yong,Kim Do Young,Ahn Sang Hoon,Han Kwang-Hyub,Yim Hyung Joon,Kim Seung Up

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region.;Zhu;Gut Liver,2016

2. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.;Liaw;Gastroenterology,1986

3. Hepatocellular carcinoma surveillance in the 21st century: saving lives or causing harm?;Hanouneh;Clin Mol Hepatol,2019

4. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.;Wong;J Clin Oncol,2010

5. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.;Chang;Hepatology,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis;Clinical Gastroenterology and Hepatology;2024-07

2. Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk;Liver International;2022-05-10

3. External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study;Cancers;2022-01-29

4. The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B;Journal of Hepatocellular Carcinoma;2021-05

5. External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals;Journal of Viral Hepatitis;2021-04-09